Supporting patient adherence

iGRO helps to give patients realistic ideas about their growth potential1. Having a realistic expectation of the short and long-term effects of growth hormone (GH) therapy is one of the most important factors for ensuring adherence to treatment.

By evaluating growth responsiveness, iGRO helps to identify children with poor adherence to treatment. The causes of poor adherence can be investigated by the physician and additional support can be provided based on the physician’s experience, with the goal of helping patients to fulfill their growth potential.



1- Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome. Kaspers S et al. Appl Health Econ Health Policy 2013;11:237–49.